Ten63 Therapeutics Secures Strategic Investment from Chugai Venture Fund and Gates Foundation

AI drug-discovery company, Ten63 Therapeutics, secures additional investment for innovative therapeutics development and strategic partnerships

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here